InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: None

Saturday, 05/21/2016 9:03:36 AM

Saturday, May 21, 2016 9:03:36 AM

Post# of 702443
Wow! Lots of excellent posts!

Want to add, regarding Adam Feuerstein's MD adviser with ties to big pharma:

Some would feel comfortable with AF's advising on the clinical side, with no understanding of those issues, because AF has an MD adviser. But I believe that adviser is Dr. Mark Ratain, the co-author of the "Feuerstein-Ratain Rule" usually referred to as an "investment thesis". This "rule" states that drugs in phase 3 will always fail if the company has a market cap below $300M.

What kind of M.D. would involve himself in writing such a paper? That is so unethical, so slimy. This "rule" depends heavily on the assumption that clinical data leaks dominate the biotech investment landscape. It also ignores the possibility of un-natural SP manipulation, yet that appears to be what Feuerstein is all about.

Add Jim Cramer as the third personality in this triangle... and what a mess. These men are exerting significant influence in the retail funding of small-cap oncology trials. Each an exceptionally screwed up human being with no ethical bones. Unbelievable!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News